To compare the long-term clinical efficacy safety and tolerability of two dosing regimens of ABT-874 compared to MTX in the treatment of moderate to severe chronic plaque psoriasis over a 52-week period
Data and Resources
- A Phase 3 Multicenter Randomized Double-blind Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Methotrexate in Subjects with Moderate to Severe Chronic Plaque Psoriasisjson
To compare the long-term clinical efficacy safety and tolerability of two...
|Release Date|| |
License Not Specified
|Public Access Level|| |